Genmab — Maj 2024

[Bulder]

Er der chance for at vi kan få de data før sommeren 25?

[Bulder]

På mandag afholder Genmab i forb. m. ASCO en Virtual mid- to late-stage pipeline update. Spm er om 1042 er midstage nok til at de afslører noget der.

[Bulder]

Kl 16

[Bulder]

Ellers kan vi vel få en reaktion på kursfaldet i forb. m. 1046.

[JKY_VH]

Tak for info Bulder

[E_L]

we are still expecting GEN1042 Phase 2 data and a decision on next steps in H2. maybe they can confirm that on monday. If they want to publish at ASH they have to sent in the abstract before
august...

[E_L]

Epcoritamab and Rybrevant on the EMA agenda this week. Also Tisotumab on Initial applications; List of questions (Day 120; Day 90 for
procedures with accelerated assessment timetable); so i guess that means they got accelerated assessment? (as the applicatoin was validated in Feb) https://www.ema.europa.eu/en/documents/agenda/agenda-chmp-meeting-27-30-may-2024_en.pdf

[Bulder]

Well they don’t want to publish at ASH. This is fluids only

[E_L]

lol, i think that is not the first time i have to be corrected on this haha.
SITC? probably even earlier

[Sukkeralf]

They could just present at the post ASH seminar

[Sukkeralf]

Otherwise SITC or ESMO

[E_L]

at least someone has epco in their list of top ASCO abstracts - Hematologic Malignancies ASCO 2024 Preview - https://www.delveinsight.com/asco-conference/article/hematologic-malignancies-preview-asco-2024?utm_source=asco&utm_medium=promotion&utm_campaign=kpr

[E_L]

Acasunlimab starting on the EMEA treadmill on the Paediatric Committee (PDCO)
Agenda https://www.ema.europa.eu/en/documents/agenda/agenda-pdco-agenda-28-31-may-2024-meeting_en.pdf

[Sukkeralf]

Top 200 drugs - darzalex nummer 11:

[Sukkeralf]

https://bpb-us-e2.wpmucdn.com/sites.arizona.edu/dist/9/130/files/2024/05/Top200BrandNameDrugBySales2023V1.pdf

[troldmanden]

Nummer 10 hvis man fraregner covid

[troldmanden]

Nummer 3 er en anden dansker. Ozempic. Den når meget tæt på 1. pladsen i år. Næste år meget klar 1. plads med den første non covid til at runde $30 mia og $40 mia

[E_L]

Genmab updated it's website to include ProfoundBio, including the pipeline https://www.genmab.com/antibody-science/pipeline

[E_L]

Let's hope the drug-developers will be as quick as the web-developers

[concillado]